Rui Wang

Sr Project Manager (Recipient of AbbVie R&D President’s Award) at Pharmacyclics, an AbbVie Company in March 2019 to January 2021

Project Manager at Pharmacyclics, an AbbVie Company in March 2018 to February 2019

Sr Associate, Project Management at Pharmacyclics, an AbbVie Company in June 2016 to February 2018

Quality Systems Specialist II at Ology Bioservices, Inc. in January 2015 to June 2016

Quality Systems Specialist I at Ology Bioservices, Inc. in July 2013 to December 2014

Research Scientist, Dept. of Pharmacotherapy and Translational Research at University of Florida in April 2013 to July 2013

Postdoctoral Research Scientist & Graduate Assistant at University of Florida in September 2007 to December 2012

Regulatory Affairs Associate & Intern at Abbott Laboratories in July 2003 to November 2006

Intern, Bio-pharmaceutical Technical and Commercial Valuation at GfK Bridgehead (formally Bridgehead International), UK in May 2005 to July 2005

Sr Project Manager at Pharmacyclics, an AbbVie Company

University of Southern California, Structure and Management of Clinical Trials, January 2016

Golden Gate University, Master of Business Administration - MBA (ongoing, expected completion 2023), January 2021 to January 2023

UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, Clinical and Industrial Drug Development, January 2016

University of Florida, Doctor of Philosophy (Ph.D.), January 2007 to January 2012

University of Nottingham, M.Sc., January 2004 to January 2005

Harvard University, Harvard ManageMentor - Business Leadership Development, January 2021 to January 2022

University of California San Diego, Certificate (awarded), Regulatory Affairs Essentials, January 2017 to January 2018

University of Southern California, Structure and Management of Clinical Trials, January 2016

Golden Gate University, Master of Business Administration - MBA (class of 2022), January 2021 to January 2022